North Macedonia vs Qatar: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- North Macedonia
- Qatar
How they compare
Qatar currently reports 28.01 deaths against 26.66 deaths in North Macedonia, a difference of 1.35 deaths.
That makes Qatar's figure about 1.1 times North Macedonia's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Qatar ahead.
North Macedonia ranks 145th and Qatar ranks 143rd of 157 countries.
North Macedonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | North Macedonia | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.0795 deaths | 0 deaths | 0.0795 deaths | North Macedonia |
| 2000s | 1.51 deaths | 0.0451 deaths | 1.46 deaths | North Macedonia |
| 2010s | 10.08 deaths | 4.48 deaths | 5.59 deaths | North Macedonia |
| 2020s | 22.82 deaths | 19.39 deaths | 3.43 deaths | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, North Macedonia or Qatar?
- Qatar, at 28.01 deaths against 26.66 deaths in North Macedonia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between North Macedonia and Qatar?
- 1.35 deaths, with Qatar ahead.
- How many years of comparable data are there for North Macedonia and Qatar?
- 35 years are reported by both, from 1990 to 2024.
- How do North Macedonia and Qatar rank globally for hiv/aids deaths averted by antiretroviral therapy?
- North Macedonia ranks 145th and Qatar ranks 143rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.